Literature DB >> 21154744

High-frequency microwave ablation method for enhanced cancer treatment with minimized collateral damage.

Jeonghoon Yoon1, Jeiwon Cho, Namgon Kim, Dae-Duk Kim, Eunsook Lee, Changyul Cheon, Youngwoo Kwon.   

Abstract

To overcome the limits of conventional microwave ablation, a new frequency spectrum above 6 GHz has been explored for low-power and low collateral damage ablation procedure. A planar coaxial probe-based applicator, suitable for easy insertion into the human body, was developed for our study to cover a wideband frequency up to 30 GHz. Thermal ablations with small input power (1-3 W) at various microwave frequencies were performed on nude mice xenografted with human breast cancer. Comparative study of ablation efficiencies revealed that 18-GHz microwave results in the largest difference in the temperature rise between cancer and normal tissues as well as the highest ablation efficiency, reaching 20 times that of 2 GHz. Thermal profile study on the composite region of cancer and fat also showed significantly reduced collateral damage using 18 GHz. Application of low-power (1 W) 18-GHz microwave on the nude mice xenografted with human breast cancer cells resulted in recurrence-free treatment. The proposed microwave ablation method can be a very effective process to treat small-sized tumor with minimized invasiveness and collateral damages.
Copyright © 2010 UICC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21154744     DOI: 10.1002/ijc.25845

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

Review 1.  Antenna Designs for Microwave Tissue Ablation.

Authors:  Hojjatollah Fallahi; Punit Prakash
Journal:  Crit Rev Biomed Eng       Date:  2018

2.  Magnetic Hyperthermia Nanoarchitectonics via Iron Oxide Nanoparticles Stabilised by Oleic Acid: Anti-Tumour Efficiency and Safety Evaluation in Animals with Transplanted Carcinoma.

Authors:  Oleg A Kulikov; Mikhail N Zharkov; Valentin P Ageev; Denis E Yakobson; Vasilisa I Shlyapkina; Andrey V Zaborovskiy; Vera I Inchina; Larisa A Balykova; Alexander M Tishin; Gleb B Sukhorukov; Nikolay A Pyataev
Journal:  Int J Mol Sci       Date:  2022-04-11       Impact factor: 6.208

3.  Design and validation of a thermoreversible material for percutaneous tissue hydrodissection.

Authors:  Alexander Johnson; Anthony Sprangers; Patrick Cassidy; Sean Heyrman; J Louis Hinshaw; Meghan Lubner; John Puccinelli; Chris Brace
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2013-11       Impact factor: 3.368

Review 4.  Irreversible electroporation in primary and metastatic hepatic malignancies: A review.

Authors:  Tianchu Lyu; Xifu Wang; Zhanliang Su; Junjie Shangguan; Chong Sun; Matteo Figini; Jian Wang; Vahid Yaghmai; Andrew C Larson; Zhuoli Zhang
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

5.  Millimeter-wave pulsed heating in vitro: cell mortality and heat shock response.

Authors:  Rosa Orlacchio; Yann Le Page; Yves Le Dréan; Rémy Le Guével; Ronan Sauleau; Stanislav Alekseev; Maxim Zhadobov
Journal:  Sci Rep       Date:  2019-10-24       Impact factor: 4.379

6.  Molecular changes in bone marrow, tumor and serum after conductive ablation of murine 4T1 breast carcinoma.

Authors:  Beata D Przybyla; Gal Shafirstein; Sagar J Vishal; Richard A Dennis; Robert J Griffin
Journal:  Int J Oncol       Date:  2013-11-21       Impact factor: 5.650

7.  In Vivo Magnetic Resonance Imaging and Microwave Thermotherapy of Cancer Using Novel Chitosan Microcapsules.

Authors:  Shunsong Tang; Qijun Du; Tianlong Liu; Longfei Tan; Meng Niu; Long Gao; Zhongbing Huang; Changhui Fu; Tengchuang Ma; Xianwei Meng; Haibo Shao
Journal:  Nanoscale Res Lett       Date:  2016-07-15       Impact factor: 4.703

8.  Use of microwave ablation for thermal treatment of solid tumors with different shapes and sizes-A computational approach.

Authors:  Masoud H H Tehrani; M Soltani; Farshad Moradi Kashkooli; Kaamran Raahemifar
Journal:  PLoS One       Date:  2020-06-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.